A woman is taking on her father's charity cycle ride from Land’s End to John O’Groats after he died suddenly half way through ...

A new study published in the Journal of Chromatography B highlights a rigorous approach to identifying and quantifying ...

ABERDEEN, Miss. (WCBI) – Voting is an essential right given to every person in the country. But not everyone uses that right when given the chance. Doubting that your vote matters is troubling to Ty ...

Markers in the blood can predict how multiple sclerosis will develop and what drugs will be ­effective, a study found.

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

Tolebrutinib delayed the onset of disability progression by 31% for patients with a type of the disease called non-relapsing ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

Available disease-modifying therapies can prevent relapses and relapse-associated worsening in people with multiple sclerosis by targeting autoimmunity through various mechanisms. However, these ...

A pioneering study presented today at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS).

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...